Fig. 2.
Principal components analysis of the microarray dataset: Sample distribution in PCA (a) IDC and (b) ILC samples with Normal tissue samples. (c) The clinical details for breast cancer samples, where age, tumor grade, tumor site, HER2, ER, PR and Triple Negative status is represented through a heatmap.
